Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Conditions:   Pulmonary Aspergillosis - Invasive;   Acute Myeloid Leukemia Interventions:   Drug: F901318;   Drug: Caspofungin Sponsors:   F2G Ltd.;   University Hospital of Cologne Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials